KRAS and familial pancreatic carcinoma: With significant and compelling evidence that aberrant KRAS protein function is critical for PDAC growth and maintenance [8,9,10], the Pancreatic Cancer Working Group (NCI) identified targeting KRAS as one of four key priorities for pancreatic cancer research [11].